202 related articles for article (PubMed ID: 26098470)
1. Role of Endothelium in Abnormal Cannabidiol-Induced Vasoactivity in Retinal Arterioles.
Su EN; Kelly ME; Cringle SJ; Yu DY
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4029-37. PubMed ID: 26098470
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature.
MacIntyre J; Dong A; Straiker A; Zhu J; Howlett SE; Bagher A; Denovan-Wright E; Yu DY; Kelly ME
Eur J Pharmacol; 2014 Jul; 735():105-14. PubMed ID: 24751709
[TBL] [Abstract][Full Text] [Related]
3. Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol.
Qiao Z; Kumar A; Kumar P; Song ZH
Exp Eye Res; 2012 Jul; 100():59-64. PubMed ID: 22580290
[TBL] [Abstract][Full Text] [Related]
4. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.
Mo FM; Offertáler L; Kunos G
Eur J Pharmacol; 2004 Apr; 489(1-2):21-7. PubMed ID: 15063151
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
6. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.
Ho WS; Hiley CR
Br J Pharmacol; 2003 Apr; 138(7):1320-32. PubMed ID: 12711633
[TBL] [Abstract][Full Text] [Related]
7. 2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling.
Su JY; Vo AC
Eur J Pharmacol; 2007 Mar; 559(2-3):189-95. PubMed ID: 17292352
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current.
Begg M; Mo FM; Offertaler L; Bátkai S; Pacher P; Razdan RK; Lovinger DM; Kunos G
J Biol Chem; 2003 Nov; 278(46):46188-94. PubMed ID: 12952947
[TBL] [Abstract][Full Text] [Related]
9. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.
Offertáler L; Mo FM; Bátkai S; Liu J; Begg M; Razdan RK; Martin BR; Bukoski RD; Kunos G
Mol Pharmacol; 2003 Mar; 63(3):699-705. PubMed ID: 12606780
[TBL] [Abstract][Full Text] [Related]
10. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
[TBL] [Abstract][Full Text] [Related]
11. The quest for endothelial atypical cannabinoid receptor: BK
Bondarenko AI; Panasiuk O; Drachuk K; Montecucco F; Brandt KJ; Mach F
Vascul Pharmacol; 2018 Mar; 102():44-55. PubMed ID: 29355732
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
Bi GH; Galaj E; He Y; Xi ZX
Addict Biol; 2020 Jul; 25(4):e12783. PubMed ID: 31215752
[TBL] [Abstract][Full Text] [Related]
14. GPR55 and the vascular receptors for cannabinoids.
Hiley CR; Kaup SS
Br J Pharmacol; 2007 Nov; 152(5):559-61. PubMed ID: 17704825
[TBL] [Abstract][Full Text] [Related]
15. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.
Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR
Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of vasorelaxation induced by the cannabidiol analogue compound O-1602 in the rat small mesenteric artery.
Al Suleimani YM; Al Mahruqi AS; Hiley CR
Eur J Pharmacol; 2015 Oct; 765():107-14. PubMed ID: 26297305
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation.
Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
Cardiovasc Res; 2015 Sep; 107(4):568-78. PubMed ID: 26092099
[TBL] [Abstract][Full Text] [Related]
18. Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment.
Krohn RM; Parsons SA; Fichna J; Patel KD; Yates RM; Sharkey KA; Storr MA
J Inflamm (Lond); 2016; 13():21. PubMed ID: 27418880
[TBL] [Abstract][Full Text] [Related]
19. 2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells.
Kreutz S; Koch M; Böttger C; Ghadban C; Korf HW; Dehghani F
Glia; 2009 Feb; 57(3):286-94. PubMed ID: 18837048
[TBL] [Abstract][Full Text] [Related]
20. Thrombin-Induced Responses via Protease-Activated Receptor 1 Blocked by the Endothelium on Isolated Porcine Retinal Arterioles.
Takahashi K; Omae T; Ono S; Kamiya T; Tanner A; Yoshida A
Curr Eye Res; 2018 Nov; 43(11):1374-1382. PubMed ID: 29966442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
